ZDHHC18 is implicated in regulating innate immunity by palmitoylating cyclic GMP-AMP synthase (cGAS), a DNA sensor. Key findings from studies using recombinant ZDHHC18 include:
Mechanistic Insight:
ZDHHC18-mediated palmitoylation at cGAS residue C474 inhibits cGAS/DNA complex formation, suppressing cGAS dimerization and downstream immune signaling .
Overexpression of ZDHHC18 reduces cGAMP production and IRF3 phosphorylation, confirming its role as a negative regulator of the cGAS-STING pathway .
Experimental Applications:
Recombinant ZDHHC18 is available in multiple formats for diverse experimental needs:
| Product ID | Species | Tag | Application |
|---|---|---|---|
| RFL21794MF | Mouse | His | Enzyme kinetics, structural studies |
| ZDHHC18-10314M | Mouse | His-Fc-Avi | Protein interaction assays |
| RFL6037RF | Rat | His | Cross-species comparative studies |
Therapeutic Targets: ZDHHC18’s regulatory role in cGAS activation highlights its potential as a drug target for autoimmune diseases and viral infections .
Tool Development: Recombinant ZDHHC18 enables high-throughput screening of palmitoylation inhibitors or activators, as seen in cadmium chloride studies .